Blog

25 March 2026 - The agenda for the July 2026 PBAC meeting is now available.  ...

20 March 2026 - The utilisation analysis public release documents from the October 2025 DUSC meeting are now available. ...

20 March 2026 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the November 2025 PBAC ...

12 March 2026 - Public comment period now open until 7 April 2026; requests to make oral comment during public ...

6 March 2026 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the November 2025 PBAC ...

6 March 2026 - The Department of Health has published an updated agenda for the March 2026 PBAC agenda (version ...

27 February 2026 - The EMA’s CHMP has recommended 12 medicines for approval at its February 2026 meeting. ...

23 February 2026 - The EMA has published a draft agenda for this week's CHMP meeting. ...

12 February 2026 - Independent appraisal committee votes reflect a net health benefit for cytisinicline alone, but uncertainty when compared ...

12 February 2026 - PHARMAC has begun work to update the Pharmaceutical Schedule to make it easier to use, faster ...

12 February 2026 - The Department of Health has published an updated agenda for the March 2026 PBAC agenda (version 5). ...

9 February 2026 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...

9 February 2026 - The Department of Health has published an updated agenda for the March 2026 PBAC agenda (version ...

26 January 2026 - The EMA has published a draft agenda for this week's CHMP meeting. ...